We are live on
!
Find out more
Arcturus Therapeutics
ARCT
ARCT
164 hedge funds and large institutions have $609M invested in Arcturus Therapeutics in 2024 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 58 increasing their positions, 49 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
45% more call options, than puts
Call options by funds: $5.34M | Put options by funds: $3.68M
18% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 49
0.47% less ownership
Funds ownership: 97.57% → 97.1% (-0.47%)
5% less capital invested
Capital invested by funds: $640M → $609M (-$30.5M)
4% less funds holding
Funds holding: 170 → 164 (-6)
21% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 29
Holders
164
Holders Change
-6
Holders Change %
-3.53%
% of All Funds
2.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
58
Reduced
49
Closed
29
Calls
$5.34M
Puts
$3.68M
Net Calls
+$1.66M
Net Calls Change
-$3.6M
Top Buyers
| 1 |
NAMA
Nikko Asset Management Americas
New York
|
+$16.1M |
| 2 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$15.2M |
| 3 |
BlackRock
New York
|
+$6.46M |
| 4 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$4.7M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.11M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$11.3M |
| 2 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$7.61M |
| 3 |
Millennium Management
New York
|
-$6.82M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$5.95M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$5.66M |
